140 related articles for article (PubMed ID: 37743595)
1. Toluidine blue 1% eye drop versus optical coherence tomography for margin delimitation of ocular surface squamous neoplasia.
Ferraz FB; Castelo Branco AMP; da Cruz LGI; Fernandes BF; Morales MC; Neto RB; Fernandes AG
Eur J Ophthalmol; 2024 May; 34(3):859-863. PubMed ID: 37743595
[TBL] [Abstract][Full Text] [Related]
2. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
Thomas BJ; Galor A; Nanji AA; El Sayyad F; Wang J; Dubovy SR; Joag MG; Karp CL
Ocul Surf; 2014 Jan; 12(1):46-58. PubMed ID: 24439046
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia.
De Arrigunaga S; Wall S; Theotoka D; Friehmann A; Camacho M; Dubovy S; Galor A; Karp CL
Ocul Surf; 2024 Jul; 33():1-10. PubMed ID: 38432640
[TBL] [Abstract][Full Text] [Related]
4. Optical Biopsy Using Anterior-Segment Optical Coherence Tomography in Ocular Surface Tumors: The Game Changer.
Ucakhan OO
Eye Contact Lens; 2024 Jun; 50(6):241-242. PubMed ID: 38778464
[No Abstract] [Full Text] [Related]
5. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia.
Romero IL; Barros Jde N; Martins MC; Ballalai PL
Cornea; 2013 Jan; 32(1):36-9. PubMed ID: 22525782
[TBL] [Abstract][Full Text] [Related]
6. Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.
Gichuhi S; Macharia E; Kabiru J; Zindamoyen AM; Rono H; Ollando E; Wanyonyi L; Wachira J; Munene R; Onyuma T; Jaoko WG; Sagoo MS; Weiss HA; Burton MJ
JAMA Ophthalmol; 2015 Nov; 133(11):1314-21. PubMed ID: 26378623
[TBL] [Abstract][Full Text] [Related]
7. How Can We Diagnose Ocular Surface Squamous Neoplasia With Optical Coherence Tomography?
Başkan C; Kılıcarslan A
Cureus; 2023 Mar; 15(3):e36320. PubMed ID: 36941905
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Response to Treatment of a Papillomatous Ocular Surface Squamous Neoplasia With Intramuscular Human Papillomavirus Vaccine.
Zein M; De Arrigunaga S; Amer MM; Galor A; Nichols AJ; Ioannides T; Dubovy SR; Karp CL
Cornea; 2024 Aug; 43(8):1049-1052. PubMed ID: 38456662
[TBL] [Abstract][Full Text] [Related]
9. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.
Atallah M; Joag M; Galor A; Amescua G; Nanji A; Wang J; Perez VL; Dubovy S; Karp CL
Ocul Surf; 2017 Oct; 15(4):688-695. PubMed ID: 28347855
[TBL] [Abstract][Full Text] [Related]
10. Anterior segment optical coherence tomography characteristics of conjunctival papilloma as compared to papilliform ocular surface squamous neoplasia.
Sripawadkul W; Khzam RA; Tang V; Zein M; Dubovy SR; Galor A; Karp CL
Eye (Lond); 2023 Apr; 37(5):995-1001. PubMed ID: 36402855
[TBL] [Abstract][Full Text] [Related]
11. Ability of novice clinicians to interpret high-resolution optical coherence tomography for ocular surface lesions.
Yim M; Galor A; Nanji A; Joag M; Palioura S; Feuer W; Karp CL
Can J Ophthalmol; 2018 Apr; 53(2):150-154. PubMed ID: 29631827
[TBL] [Abstract][Full Text] [Related]
12. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
Kieval JZ; Karp CL; Abou Shousha M; Galor A; Hoffman RA; Dubovy SR; Wang J
Ophthalmology; 2012 Mar; 119(3):481-6. PubMed ID: 22154538
[TBL] [Abstract][Full Text] [Related]
13. Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.
Tran AQ; Venkateswaran N; Galor A; Karp CL
Eye Vis (Lond); 2019; 6():27. PubMed ID: 31463333
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of white-to-white distance and anterior chamber depth measurements using the IOL Master, slit-lamp adapted optical coherence tomography and digital photographs in phakic eyes.
Wilczyński M; Pośpiech-Zabierek A
Klin Oczna; 2015; 117(3):153-9. PubMed ID: 26999937
[TBL] [Abstract][Full Text] [Related]
15. Predicted and measured retinal nerve fiber layer thickness from time-domain optical coherence tomography compared with spectral-domain optical coherence tomography.
Schrems WA; Schrems-Hoesl LM; Bendschneider D; Mardin CY; Laemmer R; Kruse FE; Horn FK
JAMA Ophthalmol; 2015 Oct; 133(10):1135-43. PubMed ID: 26225533
[TBL] [Abstract][Full Text] [Related]
16. High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia.
Singh S; Mittal R; Ghosh A; Tripathy D; Rath S
Cornea; 2018 Oct; 37(10):1292-1298. PubMed ID: 29985794
[TBL] [Abstract][Full Text] [Related]
17. Use of High-Resolution Optical Coherence Tomography in the Surgical Management of Ocular Surface Squamous Neoplasia: A Pilot Study.
Karp CL; Mercado C; Venkateswaran N; Ruggeri M; Galor A; Garcia A; Sivaraman KR; Fernandez MP; Bermudez A; Dubovy SR
Am J Ophthalmol; 2019 Oct; 206():17-31. PubMed ID: 31163136
[TBL] [Abstract][Full Text] [Related]
18. Anterior segment optical coherence tomography features of pseudoepitheliomatous hyperplasia of the ocular surface: a study of 9 lesions.
Kaliki S; Maniar A; Jakati S; Mishra DK
Int Ophthalmol; 2021 Jan; 41(1):113-119. PubMed ID: 32839863
[TBL] [Abstract][Full Text] [Related]
19. Intradevice Repeatability and Interdevice Agreement of Ocular Biometric Measurements: A Comparison of Two Swept-Source Anterior Segment OCT Devices.
Pardeshi AA; Song AE; Lazkani N; Xie X; Huang A; Xu BY
Transl Vis Sci Technol; 2020 Aug; 9(9):14. PubMed ID: 32879770
[TBL] [Abstract][Full Text] [Related]
20. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
